ArticleJournal of general internal medicine2026
Wearable-Derived Data for Patient Frailty: Extending Hospital Frailty Risk Score While Confronting Bias and Inequities.
Article in Journal of general internal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Objective, continuous measurements from wearable devices present a unique opportunity to enhance traditional, episodic clinical assessments of frailty by passively capturing real-world data on mobility, activity, and physiological signals. Integrating wearable-derived data with validated risk stratification tools like the Hospital Frailty Risk Score (HFRS) allows for earlier detection of functional decline across adults of all ages and supports timely, targeted interventions to prevent progression to severe frailty. However, deploying AI-enabled, wearable-based remote patient monitoring at scale requires confronting both device-related measurement biases and algorithmic inequities, particularly those affecting racially minoritized groups. Without rigorous validation and equity-driven calibration, these biases risk amplifying disparities in triage and clinical outcomes. This Perspective reviews recent advances in national-scale frailty risk analysis, the practical application of wearables in patient monitoring, and the critical need for performance auditing and inclusive algorithm design. It proposes a path forward for extending frailty dashboards with wearable data, emphasizing transparent validation across demographic strata, continuous post-deployment monitoring, equitable device access, and governance centered on clinical relevance. This proposal integrates continuous wearable monitoring data with the HFRS framework while centering equity-by-design principles and governance recommendations as co-equal priorities alongside technical integration. By prioritizing health need and function in algorithmic targets and validating models with locally representative data, health systems can realize the promise of AI-augmented frailty care while advancing equity and precision for all populations.
Identifiers
42420655What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.